Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Growth Forecast For Next 5 Years

Below are the top drug manufacturers-other stocks on the NASDAQ in terms of EPS growth forecast for the next five years.

earnings per share growth forecast for the next five years is 30.00 percent. Cumberland Pharmaceuticals' trailing-twelve-month revenue is $37.50 million.

EPS growth forecast for the next five years is 30.00 percent. Depomed's trailing-twelve-month operating margin is 55.30 percent.

EPS growth forecast for the next five years is 30.00 percent. POZEN's PEG ratio is 0.49.

earnings per share growth forecast for the next five years is 28.00 percent. CARDIOME PHARMA's trailing-twelve-month gross margin is 64.90 percent.